Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 30 ... to represent a company that possesses such an important, promising treatment for HIV/AIDS." About CytoDyn, Inc.: Cytolin® is a monoclonal antibody administered by ... studies being conducted at a major public teaching hospital in Boston, Massachusetts, and related corporate news as it becomes available for public distribution, among other ... by intravenous infusion and might expand the standard of treatment. In preliminary clinical trials, and in compassionate use involving hundreds of patients treated for about two ... operations. Keywords: AIDS, AIDS/HIV, Antiviral, Biotechnology, Clinical Trial Research, Clinical Trials, Communicatio, Advertising, Finance, Financial, Investing, ...
2009 NOV 28 ... Acquired Immunodeficiency Syndrome, Human Immunodeficiency Virus Bacterial Infection, AIDS, HIV, Virology, ClinicalTrial Research.This article was prepared by ... reason. The objective of this study was to measure mortality that occurs both pre-ART and during ART among HIV-positive children enrolled in two HIV-programs in Cambodia," ...
2009 NOV 30 ... therapies for HIV; launched the World Community Grid, which has done projects on cancer, aids, dengue fever; and much more For more about the Rizzoli Orthopedic ... when a child is being diagnosed, it's vital for physicians to see observations and clinical/genomic information from the parents, aunts, uncles, and other close relatives. The new ... digital mammography archive with the University of Pennsylvania; developed a clinical trial participant system with the Mayo Clinic; collaborated with Scripps to understand how ...
2009 NOV 30 ... of global impact, including seasonal & pandemic influenza, Hepatitis-C and B & HIV/AIDS. The Company's lead program is a temperature stable adjuvant free universal influenza-A ... Immune Targeting Systems (ITS) Ltd, whose synthetic universal influenza-A vaccine enters clinical trials in 2010, announced that Ken Powell has joined the board as non-executive ... antiviral cell mediated immunity. Keywords: Biotechnology, Clinical Trial Research, Flu Vaccines, Health, Immunization, Influenza Vaccines, Medical Devices, ...
2009 NOV 30 ... geriatric psychiatry, neurology and neurosurgery, adolescent and family medicine, HIV/AIDSand social and environmental medicine, among many other specialties. For more ... from the Memorial Sloan-Kettering Cancer Center, where she was a noted breast surgeon, clinicaltrial researcher and director of the breast surgery fellowship program. Dr. Montgomery ...
2009 NOV 30 ... functions of men enrolled in the cardiovascular disease substudy of the Multicenter AIDS Cohort Study who were aged > 40 years, with no self-reported history of heart disease ... evaluate the relationship between cognitive performance, risk factors for cardiovascular and cerebrovascular disease (CVD), andHIV infection in the era of highly active ... are significantly associated with performance on neuropsychological tests, and good clinical management of these factors both in HIV-infected individuals and those at risk for ... Blood Pressure, Cardiology, Cardiovascular Disease, Cerebrovascular Disease, Clinical Trial Research, Coronary Artery, Heart Disease, Neurology, Neuropsychology, Therapy, Treatment ...
2009 NOV 30 ... CA 94704-1223, USA. Keywords: City:Buenos Aires, Country:Argentina, AIDS/HIV, Clinical Research, ClinicalTrial Research, Therapy, Treatment This ... clinical trials have on patient participants are needed to ensure that all the risks and potential benefits of participating in clinical research are properly evaluated and ...
2009 NOV 30 ... Virus, Peregrine Pharmaceuticals Inc. This article was prepared by AIDS Weekly editors from staff and other reports. Copyright 2009, AIDS Weekly via ... being studied in a clinicaltrial for the treatment of patients co-infected with HCV and HIV. Phase I studies in HCV patients showed that bavituximab was well tolerated and it ...
2009 NOV 30 ... infection are similarly relevant for prognosis. We examined 81 DLBCLs from patients with AIDS in AMC010 (cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP] v ... whether immunohistochemical analyses of biopsies from patients with DLBCL having HIV infection are similarly relevant for prognosis. We examined 81 DLBCLs from patients with ... a clinically heterogeneous disease. Models based on immunohistochemistry predict clinical outcome." "These include subdivision into germinal center (GC) versus ... State:NY, Country:United States, AIDS/HIV, Biotechnology, Clinical Oncology, Clinical Trial Research, Cyclophosphamide, Doxorubicin Hydrochloride, Drugs, Epstein Barr Virus, ...
2009 NOV 30 ... "As its central basis for research, the Competence Network for HIV/AIDS (KompNet) established a nationwide cohort study on HIV/positive patients being in ... in medical care in Germany. In this paper, we describe the epidemiological composition, andclinical as well as treatment characteristics of the KompNet cohort over time," ... Keywords: City:Bochum, Country:Germany, AIDS/HIV, Clinical Research, Clinical Trial Research, Epidemiology, HIV/AIDS This article was prepared by AIDS Weekly ...
2009 NOV 30 ... P-glycoprotein activity in human immunodeficiency virus-infected participants in the AIDSClinical Trials Group study A5138," researchers in the United States report. ... in the United States report. "We studied P-glycoprotein activity on CD4 and CD8 T cells in 16 participants randomized to receive oral cyclosporin A (n = 9) or not ... Clinical Pharmacology (Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. ... States, AIDS/HIV, Antivirals, Clinical Pharmacology, Clinical Pharmacy, Clinical Trial Research, Cyclosporin, Drugs, Enzymes, HIV/AIDS, Immunodeficiency, Immunology, ...
2009 NOV 30 ... "AIDS vaccination has a pressing need for more potent vaccination vectors capable of eliciting ... need for more potent vaccination vectors capable of eliciting strong, diversified, and long-lasting cellular immune responses against human immunodeficiency virus (HIV). ... Country:France, AIDS, AIDS/HIV, Acquired Immunodeficiency Syndrome, Biotechnology, ClinicalTrial Research, Gene Therapy, Genetics, Genomics, HIV, Human Immunodeficiency Virus, ...
2009 NOV 30 ... 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were inadvertently and prematurely disclosed on the internet. Data were ... Chemicals, Chemistry, Biosciences, Biotechnology Business, Biotechnology Company, ClinicalTrial Research, HIV/AIDS, Sangamo BioSciences Inc., Treatment, Viral Inhibition, Viral ...
2009 NOV 30 ... 91320, USA. Keywords: City:Chapel Hill, State:NC, Country:United States, AIDS/HIV, ClinicalTrial Research, Mental Health, Therapy, Treatment This ... According to a study from the United States, "Participatory mapping and transect walks were used to inform the research and intervention design and to begin ...
2009 NOV 30 ... 1GB, England. Keywords: City:Los Angeles, State:CA, Country:United States, AIDS/HIV, Infectious Disease, Sexually Transmitted Diseases, Social Science This ... a control community (n = 106) receiving standard care of STD clinic, condom promotion, and peer education in two randomly assigned rural towns in West Bengal, India (Basu et al., ... researchers concluded: "This study's results demonstrate that, compared to narrowcast clinical and prevention services alone, empowerment strategies can significantly impact a broader ... significant condom use increases among female sex workers in a 16 month replication trial of the Sonagachi empowerment intervention (n = 110) compared to a control community (n = ...
2009 NOV 30 ... quarter of 2009 and, in part, by lower 2009 revenue generated by the NIAID-funded HIV/AIDS vaccine project. Revenue increased to $9.1 million for the nine months ended September ... were also lower in 2009, compared to 2008, reflecting lower employee costs and lower clinicaltrial costs as the Company completed most of its Phase 1/2 inflammatory arthritis ...
2009 NOV 23 ... concept trial of TBR-652." These data were presented at the 12th European AIDS Conference (EACS), held November 11-14, 2009 in Cologne, Germany. The poster ... Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious ... provide further basis for the continued development of TBR-652 for the treatment of HIV," said James Sapirstein, CEO. "Providing patients with well-tolerated, once-daily ...
2009 NOV 29 ... more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDSand malaria combined.However, the risk for women is largely under-estimated, ... women are underrepresented in cardiovascular research in Europe. "In the 62 randomized clinical trials published between 2006 and July 2009, only 33.5% of enrolled participants were ... Syndrome, Angiology, Bariatrics, Cancer, Cardiology, Cardiovascular Disease, Clinical Trial Research, Diabetes, Gynecology, HIV, Heart Disease, Heart Failure, Hormones, Human ...
2009 NOV 30 ... Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by ... this announcement, Zyomyx is currently entering the commercial phase of this project and is actively soliciting partnerships with global sales and distribution providers. ... a simple visual readout. The quantitative CD4 count provides critical information in the clinical management of HIV. The test will give doctors and patients in resource-poor settings ... assessed against the predicate method of flow cytometry. Results from the verification trial showed that only Zyomyx's CD4 test compared favorably with those generated using the ...
